Details for New Drug Application (NDA): 212019
✉ Email this page to a colleague
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 212019
Tradename: | BUMETANIDE |
Applicant: | Rising |
Ingredient: | bumetanide |
Patents: | 0 |
Pharmacology for NDA: 212019
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 212019
Suppliers and Packaging for NDA: 212019
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUMETANIDE | bumetanide | TABLET;ORAL | 212019 | ANDA | Rising Pharma Holdings, Inc | 16571-677 | 16571-677-01 | 100 TABLET in 1 BOTTLE (16571-677-01) |
BUMETANIDE | bumetanide | TABLET;ORAL | 212019 | ANDA | Rising Pharma Holdings, Inc | 16571-677 | 16571-677-10 | 1000 TABLET in 1 BOTTLE (16571-677-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Dec 12, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Dec 12, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Dec 12, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription